I have no idea how Genentech or Roche's books are looking but if they need to use up money in this financial year and then move on it wouldn't be surprising for them to make their decision in coming weeks as opposed to carrying it over for another 5 months. In saying that though the vast majority of PYC's deals have been working towards end of calendar year and coming from mid-late December although I think Genentech's 12 months since being handed the data actually falls in November ?
I have no idea how Genentech or Roche's books are looking but if...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |